Dawn Qingqing Chong

Dawn Qingqing Chong

Auto-generated profile, based on publicly available information

Dawn Qingqing Chong

National Cancer Centre, Singapore 6 Division of Medical Oncology,

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Hepatology
Verified
Journal Article
Closed access
JPJessica L. Petrick
Jessica L. Petrick
AFAndrea A. Florio
Andrea A. Florio
XZXuehong Zhang
Xuehong Zhang
AZAnne Zeleniuch‐Jacquotte
Anne Zeleniuch‐Jacquotte
PWProf. Dr. Jean Wactawski-Wende
Prof. Dr. Jean Wactawski-Wende
KMKatherine McGlynn
Katherine McGlynn

17 June 2024 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
RSRaghuvaran Shanmugam
Raghuvaran Shanmugam
PMPrativa Majee
Prativa Majee
WSWei Shi
Wei Shi
MOMert Burak Ozturk
Mert Burak Ozturk
TVThamil Selvan. Vaiyapuri
Thamil Selvan. Vaiyapuri
Vinay TergaonkarVinay Tergaonkar
Vinay Tergaonkar
Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with an increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by reactivating the dormant human telomerase reverse transcriptase (hTERT) subunit of the telomerase holoenzyme in an iron-(Fe3+)-dependent manner and thereby drives colorectal cancers. Chemical genetic screens combined with isothermal dose-response fingerprinting and mass spectrometry identified a small molecule SP2509 that specifically inhibits Pirin-mediated hTERT reactivation in colorectal cancers by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat and increased incidence of colorectal cancers. Small molecules like SP2509 represent a novel modality to target telomerase that acts as a driver of 90% of human cancers and is yet to be targeted in clinic. Significance: We show how iron-(Fe3+) in collusion with genetic factors reactivates telomerase, providing a molecular mechanism for the association between iron overload and increased incidence of colorectal cancers. Although no enzymatic inhibitors of telomerase have entered the clinic, we identify SP2509, a small molecule that targets telomerase reactivation and function in colorectal cancers.

7 June 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
ISIsaac Seow-En
Isaac Seow-En
ACAik Yong Chok
Aik Yong Chok
DMDavid B. Matchar
David B. Matchar
SYSungwon Yoon
Sungwon Yoon
DCDawn Qingqing Chong
Dawn Qingqing Chong
ETEmile Kwong‐Wei Tan
Emile Kwong‐Wei Tan

15 July 2021 in Cancer Prevention Research
Verified
Journal Article
Open access
PDF file
TSTracey G. Simon
Tracey G. Simon
MKMi Na Kim
Mi Na Kim
XLXiao Luo
Xiao Luo
XLXing Liu
Xing Liu
WYWanshui Yang
Wanshui Yang
XZXuehong Zhang
Xuehong Zhang
Prospective data are limited regarding dynamic adulthood weight changes and hepatocellular carcinoma (HCC) risk. We included 77,238 women (1980–2012) and 48,026 men (1986–2012), who recalled young-adult weight [age 18 years (women); 21 years (men)], and provided biennially updated information regarding weight, body mass index (BMI), and comorbidities. Overall adulthood weight change was defined as the difference in weight (kilograms) between young-adulthood and present. Using Cox proportional hazards models, we calculated multivariable adjusted HRs (aHR) and 95% confidence intervals (CI). Over 3,676,549 person-years, we documented 158 incident HCC cases. Elevated HCC risk was observed with higher BMI in both young-adulthood and later-adulthood [continuous aHRs per each 1 unit = 1.05; 95% CI = 1.02–1.09 (Ptrend = 0.019), and 1.08; 95% CI = 1.06–1.10 (Ptrend = 0.004), respectively]. Moreover, overall adulthood weight gain was also significantly associated with increased HCC risk (aHR per each 1-kg increase = 1.03; 95% CI = 1.01–1.08; Ptrend = 0.010), including after further adjusting for young-adult BMI (Ptrend = 0.010) and later-adult BMI (Ptrend = 0.008). Compared with adults with stable weight (±5 kg), the multivariable-aHRs with weight gain of 5–<10 kg, 10–<20 kg, and ≥20 kg were, 1.40 (95% CI = 0.67–2.16), 2.09 (95% CI = 1.11–3.95), and 2.61 (95% CI = 1.42–5.22), respectively. In two prospective, nationwide cohorts, adulthood weight gain was significantly associated with increased HCC risk. Prevention Relevance: Our data suggest that maintaining a stable weight during adulthood, specifically by preventing weight gain, could represent an important public health strategy for the prevention of hepatocellular carcinoma.

30 April 2015 in Expert Review of Anticancer Therapy
Verified
Journal Article
Closed access
EWEvelyn Yi Ting Wong
Evelyn Yi Ting Wong
CCClarinda Chua
Clarinda Chua
SBSok Yuen Beh
Sok Yuen Beh
DKDennis Koh
Dennis Koh
DCDawn Chong
Dawn Chong
ITIain Beehuat Tan
Iain Beehuat Tan
Colorectal cancer (CRC) is one of the three topmost common cancers in men and the second most common cancer in women worldwide. With current advances in the medical and surgical treatment of CRC, care has slowly transformed to curative treatment. With these advances, CRC survivors are increasing in numbers and these patients have a unique range of medical, physical and psychological needs that require regular follow-up. In 2006, the Institute of Medicine recommended that cancer survivors who are completing primary treatment receive a survivorship care plan. There are many different programs of different complexity that are implemented for CRC survivors. This review outlines the needs of CRC survivors, the current surveillance techniques used in the continuing care of patients with CRC after curative treatment and the evidence behind these strategies.

14 February 2025 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
LCLionel Raphael Hui Chen
Lionel Raphael Hui Chen
QCQingqing Dawn Chong
Qingqing Dawn Chong
BTBrenda Tay
Brenda Tay
SZSiqin Zhou
Siqin Zhou
EWEvelyn Yi Ting Wong
Evelyn Yi Ting Wong
STSze Huey Tan
Sze Huey Tan
Background: Colorectal cancer (CRC) incidence and mortality in those aged 50 years and above have decreased over the past 2 decades. However, there is a rising incidence of CRC among individuals under 50 years of age, termed early-onset colorectal cancer (EOCRC). Patients with EOCRC are diagnosed at an advanced stage and may be in more psychosocial, emotional, and financial distress. Objective: Our study examined the epidemiological shifts in CRC in Singapore, a multiethnic country. Methods: CRCs diagnosed at age 20 years and above were identified from the Singapore Cancer Registry (SCR) from 1968 to 2019. Patient characteristics included gender, ethnicity, and age of CRC diagnosis. Population information was obtained from the Department of Statistics Singapore (SingStat). Age-specific incidence rates (ASRs) and age-standardized incidence rates (ASIRs) were calculated. The cohort was divided into 3 age groups: 20-49, 50-64, and ≥65 years. Temporal trends in incidence rates were modeled with joinpoint regression. Birth cohort models were fitted using the National Cancer Institute (NCI) age-period-cohort analysis tool. Cancer-specific survival analysis was performed with the Cox proportional hazards model. Results: In total, 53,044 CRCs were included, and 6183 (11.7%) adults aged 20-49 years were diagnosed with EOCRC. The ASR of EOCRC rose from 5 per 100,000 population in 1968 to 9 per 100,000 population in 1996 at 2.1% annually and rose to 10 per 100,000 population in 2019 at 0.64% annually. The ASR for CRC among adults aged 50-64 years rose at 3% annually from 1968 to 1987 and plateaued from 1987, while the ASR for adults aged 65 years and above rose at 4.1% annually from 1968 to 1989 and 1.3% annually from 1989 to 2003 but decreased from 2003 onwards at 1% annually. The ASR of early-onset rectal cancer increased significantly at 1.5% annually. There was a continued rise in the ASR of EOCRC among males (annual percentage change [APC] 1.5%) compared to females (APC 0.41%). Compared to the 1950-1954 reference birth cohort, the 1970-1984 birth cohort had a significantly higher incidence rate ratio (IRR) of 1.17-1.36 for rectal cancer, while there was no significant change for colon cancer in later cohorts. There were differences in CRC trends across the 3 ethnic groups: Malays had a rapid and persistent rise in the ASR of CRC across all age groups (APC 1.4%-3%), while among young Chinese, only the ASR of rectal cancer was increasing (APC 1.5%). Patients with EOCRC had better survival compared to patients diagnosed at 65 years and above (hazard ratio [HR] 0.73, 95% CI 0.67-0.79, P<.001) after adjusting for covariates. Conclusions: The rise in the incidence of rectal cancer among young adults, especially among Chinese and Malays, in Singapore highlights the need for further research to diagnose CRC earlier and reduce cancer-related morbidity and mortality.